Showing results (161-170 of 305) with videos related to

Sort By:
Pageof 31
La Revue De Medecine Interne|December 19, 2015
[Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma]N Issa, B Blondeau, S Dimicoli-Salazar, et al.
Human Gene Therapy|January 1, 1995
Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transferF Moreau-Gaudry, C Ged, C Barbot, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1982
[Comparison of platelets frozen with different cryoprotective agents]G Vezon, Y Piquet, M Boisseau, et al.
British Journal of Haematology|August 29, 1998
Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferonJ Reiffers, K Taylor, E Gluckman, et al.
Leukemia|November 22, 1997
Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemiaF Lacombe, F Durrieu, A Briais, et al.
Annales De Dermatologie Et De Venereologie|December 23, 2006
[Multiple verruciform xanthomas of the oral mucosa associated with graft versus host disease]V Sibaud, G Marit, C Deminière, et al.
Cytometry|November 30, 1999
Synthesis of Bcl-2 in response to anthracycline treatment may contribute to an apoptosis-resistant phenotype in leukemic cell linesF Durrieu, M A Belaud-Rotureau, F Lacombe, et al.
Bone Marrow Transplantation|June 1, 2000
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, N C Gorin, et al.
Journal of Neurology|June 1, 1990
Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classificationC Vital, A Vital, J Julien, et al.
Cytometry|November 20, 1998
Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantationS Cotteret, F Belloc, J M Boiron, et al.
Pageof 31